IL269364B - A process for the large-scale production of tricyclic aminoglycosides and their intermediates - Google Patents

A process for the large-scale production of tricyclic aminoglycosides and their intermediates

Info

Publication number
IL269364B
IL269364B IL269364A IL26936419A IL269364B IL 269364 B IL269364 B IL 269364B IL 269364 A IL269364 A IL 269364A IL 26936419 A IL26936419 A IL 26936419A IL 269364 B IL269364 B IL 269364B
Authority
IL
Israel
Prior art keywords
intermediates
pseudo
large scale
scale preparation
trisaccharide aminoglycosides
Prior art date
Application number
IL269364A
Other languages
English (en)
Hebrew (he)
Other versions
IL269364A (en
Inventor
Mizhiritskii Michael
Bushan Kotala Mani
Paladi Ravinder
Original Assignee
Eloxx Pharmaceuticals Ltd
Mizhiritskii Michael
Bushan Kotala Mani
Paladi Ravinder
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eloxx Pharmaceuticals Ltd, Mizhiritskii Michael, Bushan Kotala Mani, Paladi Ravinder filed Critical Eloxx Pharmaceuticals Ltd
Publication of IL269364A publication Critical patent/IL269364A/en
Publication of IL269364B publication Critical patent/IL269364B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/224—Cyclohexane rings substituted by at least two nitrogen atoms with only one saccharide radical directly attached to the cyclohexyl radical, e.g. destomycin, fortimicin, neamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/228—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings
    • C07H15/23—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings with only two saccharide radicals in the molecule, e.g. ambutyrosin, butyrosin, xylostatin, ribostamycin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL269364A 2017-03-15 2019-09-15 A process for the large-scale production of tricyclic aminoglycosides and their intermediates IL269364B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201721008996 2017-03-15
PCT/IL2018/050306 WO2018167794A1 (en) 2017-03-15 2018-03-15 Large scale preparation of pseudo-trisaccharide aminoglycosides and of intermediates thereof

Publications (2)

Publication Number Publication Date
IL269364A IL269364A (en) 2019-11-28
IL269364B true IL269364B (en) 2022-04-01

Family

ID=63521924

Family Applications (1)

Application Number Title Priority Date Filing Date
IL269364A IL269364B (en) 2017-03-15 2019-09-15 A process for the large-scale production of tricyclic aminoglycosides and their intermediates

Country Status (9)

Country Link
US (2) US11136345B2 (enExample)
EP (1) EP3609902A4 (enExample)
JP (1) JP7187471B2 (enExample)
CN (2) CN117466958A (enExample)
AU (2) AU2018235441C1 (enExample)
BR (1) BR112019018834A2 (enExample)
CA (1) CA3055883A1 (enExample)
IL (1) IL269364B (enExample)
WO (1) WO2018167794A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021061873A1 (en) * 2019-09-23 2021-04-01 Eloxx Pharmaceuticals, Inc. Methods, compositions, and kits for treating polycystic kidney disease

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897412A (en) 1972-05-04 1975-07-29 Bristol Myers Co Paromomycin antibiotic derivatives
FR2232326B1 (enExample) 1973-06-05 1977-11-10 Pfizer
US4029882A (en) 1974-03-19 1977-06-14 Schering Corporation Selective acylation of the C-1 amino group of aminoglycoside antibiotics
US3996205A (en) 1975-09-08 1976-12-07 The Upjohn Company Aminoglycoside antibiotics and intermediates
JPS543043A (en) 1977-06-10 1979-01-11 Meiji Seika Kaisha Ltd Amino-glycoside antibiotics; 1-n-(omega-aminoalkanesulfonyl)derivatives and their preparation
FR2427341A1 (fr) 1978-06-02 1979-12-28 Delalande Sa Nouveaux derives aminoglycosidiques hemisynthetiques, leur procede de preparation et leur application en therapeutique
JPH0446189A (ja) 1990-06-08 1992-02-17 Meiji Seika Kaisha Ltd 新規なリボスタマイシン誘導体
SI2390255T1 (sl) 2006-04-03 2016-12-30 Technion Research & Development Foundation Ltd. Novi aminoglikozidi in njihove uporabe pri zdravljenju genetskih motenj
WO2011044538A1 (en) * 2009-10-09 2011-04-14 Achaogen, Inc. Antibacterial aminoglycoside analogs
SMT201800019T1 (it) * 2010-11-18 2018-03-08 Technion Res & Dev Foundation Amminoglicosidi e relativi usi nel trattamento di malattie genetiche
JP2017516835A (ja) * 2014-06-05 2017-06-22 エロックス ファーマシューティカルズ リミテッド レット症候群治療におけるアミノグリコシド類縁体の使用
EP3344641A4 (en) 2015-09-02 2019-09-18 Eloxx Pharmaceuticals Ltd. AMINO-LIKES DERIVATIVES AND USES THEREOF FOR THE TREATMENT OF GENETIC DISEASES
US11306115B2 (en) * 2015-09-02 2022-04-19 Eloxx Pharmaceuticals Ltd. Aminoglycoside derivatives and uses thereof in treating genetic disorders
US10786520B2 (en) * 2015-09-02 2020-09-29 Eloxx Pharmaceuticals Ltd. Aminoglycoside derivatives and uses thereof in treating genetic disorders

Also Published As

Publication number Publication date
CN110637024B (zh) 2023-10-24
CN110637024A (zh) 2019-12-31
US20200079809A1 (en) 2020-03-12
CN117466958A (zh) 2024-01-30
AU2018235441B2 (en) 2022-07-21
JP2020514373A (ja) 2020-05-21
CA3055883A1 (en) 2018-09-20
JP7187471B2 (ja) 2022-12-12
US20220033428A1 (en) 2022-02-03
AU2018235441A2 (en) 2019-11-07
AU2018235441A1 (en) 2019-09-26
AU2022256098A1 (en) 2022-11-17
AU2022256098B2 (en) 2024-07-11
AU2018235441C1 (en) 2024-10-24
EP3609902A1 (en) 2020-02-19
AU2022256098C1 (en) 2024-10-31
BR112019018834A2 (pt) 2020-04-14
IL269364A (en) 2019-11-28
EP3609902A4 (en) 2021-01-06
US11136345B2 (en) 2021-10-05
WO2018167794A1 (en) 2018-09-20

Similar Documents

Publication Publication Date Title
IL286316A (en) New micro-dystrophins and related method of use
IL292648A (en) A process for the preparation of glucuronide-drug binders and their intermediates
GB2569748B (en) Measurement of tissue viability
SI3380530T1 (sl) Izboljšan postopek za pripravo sugamadeksa in njegovih intermediatov
ZA202003590B (en) Process for the preparation of opicapone and intermediates thereof
SG11202004381WA (en) Production of guaiene and rotundone
IL269409A (en) Combinations of chk1- and wee1 - inhibitors
GB201512607D0 (en) Calibration of transducers
PT3661491T (pt) 3-metilmetcatinona para uso no tratamento de um indivíduo sob uma intervenção psicoterapêutica
HUE062956T2 (hu) Eljárások niraparib és köztitermékei elõállítására
IL269455B1 (en) Time of flight sensor
GB201704443D0 (en) Time of flight sensor
IL275655A (en) A process for the preparation of amino-pyrimidine and its intermediates
IL255819A (en) An improved process for the preparation of sofosbuvir and intermediates
ZA201701976B (en) Synthesis of ent-progesterone and intermediates thereof
PL3449931T3 (pl) Zastosowanie cerebrolizyny
IL269364B (en) A process for the large-scale production of tricyclic aminoglycosides and their intermediates
IL253077A0 (en) Process and intermediates for the preparation of Fermpanel
HK40013466A (en) Large scale preparation of pseudo-trisaccharide aminoglycosides and of intermediates thereof
GB2537518B (en) Settable compositions and methods of use
GB201721386D0 (en) Chrondogy of time-wave
GB201708700D0 (en) Improvements of magflow meters
GB201707716D0 (en) Point of interest location specification
GB201709211D0 (en) A novel composition and methods of preparation thereof
HK1238297A1 (en) Novel micro-dystrophins and related methods of use